<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01099956</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2009/28</org_study_id>
    <nct_id>NCT01099956</nct_id>
  </id_info>
  <brief_title>Low Grade Inflammation in Type 1 Diabetes Children</brief_title>
  <acronym>Coccinelle</acronym>
  <official_title>Low Grade Inflammation in Type 1 Diabetes Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study propose to measure the inflammation level in type 1 diabetes children with the
      cytokine analysis compared to non diabetic children of the same sibling and to healthy
      children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The increase of type 1 diabetes incidence, particularly in young children leads to conduce
      new diagnostic and therapeutic strategies, notably for associated chronic
      morbidity.Measurement of chronic inflammation, with modification of the balance between
      pro-inflammatory cytokines and anti-inflammatory cytokines, could lead to detect patients
      with high risk to diabetes chronic morbidity.

      After parental consent, blood sampling will be carried out by micromethod for cytokine (500
      µl) and CRPhs dosages and glycemia (100 µl) and glycated hemoglobin (1 µl). Urine will be
      collected (50 ml) in the morning for further researches.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of Interleukine 6 in group DTI versus control group</measure>
    <time_frame>Once at inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase of others cytokines (IL1-beta, l'IL-4, l'IL-10 and TNF alpha) and increase of High sensitivity CRP in group DTI versus control group</measure>
    <time_frame>Once at inclusion</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>diabetes group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        60 children in type 1 diabetes group and 30 children in control group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Type 1 diabetes children group :

          -  Children aged 2 to 17 years

          -  Type 1 diabetes children

        Controlled group :

          -  Children aged 2 to 17 years

          -  Brother or sister of type 1 diabetes children

        Exclusion Criteria:

          -  Per os or inhaled corticoid in the previous month of inclusion

          -  Acute infectious disease in the previous week of inclusion

          -  Other chronic disease than diabetes type1
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal BARAT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children Hospital, Endocrinology Unit</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2010</study_first_submitted>
  <study_first_submitted_qc>April 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2010</study_first_posted>
  <last_update_submitted>October 24, 2011</last_update_submitted>
  <last_update_submitted_qc>October 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>children</keyword>
  <keyword>low grade inflammation</keyword>
  <keyword>cytokine</keyword>
  <keyword>CRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

